Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Tyra Biosciences, Inc. (TYRA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-28.10M |
|
-- |
|
-- |
|
$31.45M |
|
$-31.45M |
|
$3.35M |
|
$-28.10M |
|
$-28.10M |
|
$-28.10M |
|
$-28.10M |
|
$-28.10M |
|
$-28.10M |
|
$-31.45M |
|
$-31.31M |
|
59.55M |
|
59.55M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$302.15M |
|
$1.41M |
|
$19.34M |
|
$321.50M |
|
$13.77M |
|
-- |
|
$5.58M |
|
$19.35M |
|
$302.15M |
|
$302.15M |
|
$302.15M |
|
53.23M |
|
| Cash Flow Statement Financials | |
$-49.14M |
|
$52.89M |
|
$2.77M |
|
$92.97M |
|
$99.49M |
|
$6.52M |
|
$12.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.94 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.30% |
|
-9.30% |
|
-8.74% |
|
-9.30% |
|
$5.68 |
|
$-0.83 |
|
$-0.83 |
|